IRIX vs. RMTI, ELMD, FONR, VANI, HYPR, CUTR, POCI, ECOR, MOVE, and PXDT
Should you be buying IRIDEX stock or one of its competitors? The main competitors of IRIDEX include Rockwell Medical (RMTI), Electromed (ELMD), FONAR (FONR), Vivani Medical (VANI), Hyperfine (HYPR), Cutera (CUTR), Precision Optics (POCI), electroCore (ECOR), Movano (MOVE), and Pixie Dust Technologies (PXDT).
IRIDEX (NASDAQ:IRIX) and Rockwell Medical (NASDAQ:RMTI) are both small-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, community ranking, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations.
Rockwell Medical received 30 more outperform votes than IRIDEX when rated by MarketBeat users. However, 69.04% of users gave IRIDEX an outperform vote while only 57.31% of users gave Rockwell Medical an outperform vote.
IRIDEX currently has a consensus target price of $2.00, suggesting a potential downside of 17.70%. Rockwell Medical has a consensus target price of $7.00, suggesting a potential upside of 298.86%. Given Rockwell Medical's stronger consensus rating and higher possible upside, analysts clearly believe Rockwell Medical is more favorable than IRIDEX.
20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are owned by institutional investors. 6.2% of IRIDEX shares are owned by insiders. Comparatively, 1.9% of Rockwell Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Rockwell Medical has higher revenue and earnings than IRIDEX. Rockwell Medical is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks.
Rockwell Medical has a net margin of -9.72% compared to IRIDEX's net margin of -21.92%. Rockwell Medical's return on equity of -28.29% beat IRIDEX's return on equity.
In the previous week, Rockwell Medical had 1 more articles in the media than IRIDEX. MarketBeat recorded 4 mentions for Rockwell Medical and 3 mentions for IRIDEX. IRIDEX's average media sentiment score of 0.85 beat Rockwell Medical's score of 0.73 indicating that IRIDEX is being referred to more favorably in the media.
IRIDEX has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Comparatively, Rockwell Medical has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500.
Summary
Rockwell Medical beats IRIDEX on 13 of the 18 factors compared between the two stocks.
Get IRIDEX News Delivered to You Automatically
Sign up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IRIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
